Hemogenyx Pharmaceuticals Plc (HEMO.L)

GBp 184.5

(2.5%)

Net Debt Summary of Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc's latest annual net debt in 2023 was 1.69 Million GBP , up 90.8% from previous year.
Hemogenyx Pharmaceuticals Plc's latest quarterly net debt in 2024 Q2 was -1.38 Million GBP , up 169.48% from previous quarter.
Hemogenyx Pharmaceuticals Plc reported annual net debt of 890.07 Thousand GBP in 2022, up 113.03% from previous year.
Hemogenyx Pharmaceuticals Plc reported annual net debt of -6.83 Million GBP in 2021, down -3609.03% from previous year.
Hemogenyx Pharmaceuticals Plc reported quarterly net debt of -1.64 Million GBP for 2024 Q1, down -196.73% from previous quarter.
Hemogenyx Pharmaceuticals Plc reported quarterly net debt of 180.2 Thousand GBP for 2023 Q2, up 167.33% from previous quarter.

Annual Net Debt Chart of Hemogenyx Pharmaceuticals Plc (2023 - 2014)

Historical Annual Net Debt of Hemogenyx Pharmaceuticals Plc (2023 - 2014)

Year	Net Debt	Net Debt Growth
2023	1.69 Million GBP	90.8%
2022	890.07 Thousand GBP	113.03%
2021	-6.83 Million GBP	-3609.03%
2020	-184.16 Thousand GBP	-124.28%
2019	758.57 Thousand GBP	228.66%
2018	-589.6 Thousand GBP	68.58%
2017	-1.87 Million GBP	-152.01%
2016	-744.66 Thousand GBP	-483.83%
2015	194 Thousand GBP	3214.09%
2014	-6230.00 GBP	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	-1.38 Million GBP	169.48%
2024 Q1	-1.64 Million GBP	-196.73%
2023 Q2	180.2 Thousand GBP	167.33%
2023 Q4	1.69 Million GBP	19.16%
2023 Q3	1.42 Million GBP	690.89%
2023 FY	1.69 Million GBP	90.8%
2023 Q1	-267.63 Thousand GBP	-130.07%
2022 Q1	-5.79 Million GBP	15.1%
2022 Q4	890.07 Thousand GBP	56.73%
2022 Q2	-5.79 Million GBP	0.0%
2022 FY	890.07 Thousand GBP	113.03%
2022 Q3	567.92 Thousand GBP	109.79%
2021 FY	-6.83 Million GBP	-3609.03%
2021 Q2	-9.03 Million GBP	0.32%
2021 Q3	-6.84 Million GBP	24.24%
2021 Q4	-6.83 Million GBP	0.15%
2021 Q1	-9.05 Million GBP	-4819.09%
2020 Q3	-222.89 Thousand GBP	86.13%
2020 Q1	-1.65 Million GBP	-317.85%
2020 Q2	-1.6 Million GBP	2.76%
2020 FY	-184.16 Thousand GBP	-124.28%
2020 Q4	-184.16 Thousand GBP	17.37%
2019 Q1	84.27 Thousand GBP	114.29%
2019 FY	758.57 Thousand GBP	228.66%
2019 Q2	84.27 Thousand GBP	0.0%
2019 Q4	758.57 Thousand GBP	5.55%
2019 Q3	718.68 Thousand GBP	752.82%
2018 Q2	-1.24 Million GBP	0.0%
2018 Q1	-1.24 Million GBP	33.77%
2018 Q3	-589.6 Thousand GBP	52.56%
2018 Q4	-589.6 Thousand GBP	0.0%
2018 FY	-589.6 Thousand GBP	68.58%
2017 Q1	87.22 Thousand GBP	108.34%
2017 FY	-1.87 Million GBP	-152.01%
2017 Q2	-929.27 Thousand GBP	-1165.4%
2017 Q3	-1.87 Million GBP	-101.95%
2017 Q4	-1.87 Million GBP	0.0%
2016 FY	-744.66 Thousand GBP	-483.83%
2016 Q4	-1.04 Million GBP	0.0%
2016 Q2	-1.21 Million GBP	0.0%
2015 FY	194 Thousand GBP	3214.09%
2014 FY	-6230.00 GBP	0.0%

Peer Net Debt Comparison of Hemogenyx Pharmaceuticals Plc

Name	Net Debt	Net Debt Difference